Axogen completes BioCircuit Technologies acquisition
Axogen said it completed its acquisition of BioCircuit Technologies and added NerveTape, described as the first FDA-cleared device for sutureless peripheral nerve repair.
Story updates
09:19:28 PM UTC
SquawkNews
Axogen Completes Acquisition Of BioCircuit Technologies, Adding NerveTape(TM), The First FDA Cleared Device For Sutureless Peripheral Nerve Repair >AXGN